Myeloperoxidase (MPO) Activity Assay Kit
中文名称:髓过氧化物酶(MPO)比色法测试盒

Price:
Size:
96 T (48 samples)
48 T (24 samples)
- 样本类型: 血清(浆);乳汁;动物组织
- 检测仪器及波长: 酶标仪(450-470 nm,最佳检测波长为460 nm)
- 研究领域: 氧化应激
为了简化计算过程,可下载该产品计算文件。如使用中有任何问题,请随时联系技术支持
说明书或网站上未涉及的样本类型请先跟技术支持沟通,可进行售前验证
根据需测样本数,试剂盒测样本孔数和单个样本测量孔数来计算所需生化试剂盒数量,请点击按钮 计算
检测原理 |
髓过氧化物酶将过氧化氢还原成一种复合物,该复合物通过供氢体邻联茴香胺供氢后生成黄色产物,在460 nm处通过比色法测定产物的生成量,从而计算出MPO的活力。
|
指标简称 | MPO |
灵敏度 | 19.42 U/L |
检测范围 | 19.42-893.31 U/L |
精密度 | 批间差:7.3% | 批内差:5.4% |
样本量 | 45-90 μL |
检测时间 | 1 h 10 min |
检测仪器及波长 | 酶标仪(450-470 nm,最佳检测波长为460 nm) |
保存条件 | 该产品可在 2-8°C避光条件下保存6个月。 |
有效期 | 6个月 |
-
A high salt diet impairs the bladder epithelial barrier and activates the NLRP3 and NF?κB signaling pathways to induce an overactive bladder in vivo
IF: 2.400 -
MiR-497-5p ameliorates the oxyhemoglobin-induced subarachnoid hemorrhage injury in vitro by targeting orthodenticle homeobox protein 1 (Otx1) to activate the Nrf2/HO-1 pathway
IF: 2.300 -
Gentiopicroside Ameliorates Sepsis-Induced Acute Lung Injury via Inhibiting Inflammatory Response
IF: 2.100Journal: Canadian Respiratory Journal (2024)Reactivity:RatSample Type:lung tissue -
Danshensu methyl ester attenuated LPS-induced acute lung injury by inhibiting TLR4/NF-κB pathway
IF: 1.900Journal: RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2024)Reactivity:MouseSample Type:lung -
IRF7 Activates LCN2 Transcription to Enhance LPS-Induced Acute Lung Injury by Inducing Macrophage Ferroptosis and M1 Polarization
IF: 1.800Journal: CELL BIOCHEMISTRY AND BIOPHYSICS (2024)Reactivity:MouseSample Type:lung tissue -
Maternal Exposure to E 551 during Pregnancy Leads to Genome-wide DNA Methylation Changes and Metabolic Disorders in the Livers of Pregnant Mice and Their Fetuses
IF: 13.600Journal: JOURNAL OF HAZARDOUS MATERIALS (2023)PMID:38118196Reactivity:MouseSample Type:liver tissue -
Oral Metal-Free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD)
IF: 13.300 -
Modulation of tryptophan metabolism via AHR-IL22 pathway mediates the alleviation of DSS-induced colitis by chitooligosaccharides with different degrees of polymerization
IF: 11.200 -
Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment
IF: 10.200 -
Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion
IF: 10.200